ilShinbiobase Co. Ltd (068330) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.053x

Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) has a cash flow conversion efficiency ratio of 0.053x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.46 Billion ≈ $2.34 Million USD) by net assets (₩65.35 Billion ≈ $44.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View ilShinbiobase Co. Ltd (068330) share price today for real-time trading data and today's change.

ilShinbiobase Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how ilShinbiobase Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see ilShinbiobase Co. Ltd (068330) market capitalisation for the company's overall valuation and market capitalisation.

ilShinbiobase Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ilShinbiobase Co. Ltd ranked by their cash flow conversion efficiency. Also see ilShinbiobase Co. Ltd balance sheet assets for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Qleanair Holding AB ST:QAIR	0.114x
SEOJEON ELECTRIC MACHINERY Co.Ltd KQ:189860	-0.176x
Sustainable Power & Infrastructure Split Corp TO:PWI	0.089x
Finetechnix. Co.Ltd KQ:106240	-0.063x
Naos Small Cap Opportunities Company Ltd AU:NSC	0.063x
Bubang Co. Ltd KQ:014470	0.043x
Tate & Lyle PLC LSE:TATE	0.074x
Ajinextek Co. Ltd KQ:059120	0.053x

Annual Cash Flow Conversion Efficiency for ilShinbiobase Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of ilShinbiobase Co. Ltd from 2014 to 2025. Review ilShinbiobase Co. Ltd financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩64.80 Billion ≈ $43.91 Million	₩5.27 Billion ≈ $3.57 Million	0.081x	+19.22%
2024-12-31	₩60.45 Billion ≈ $40.97 Million	₩4.12 Billion ≈ $2.79 Million	0.068x	-34.34%
2023-12-31	₩57.06 Billion ≈ $38.67 Million	₩5.92 Billion ≈ $4.01 Million	0.104x	+111.12%
2022-12-31	₩53.82 Billion ≈ $36.47 Million	₩2.65 Billion ≈ $1.79 Million	0.049x	-63.21%
2021-12-31	₩50.47 Billion ≈ $34.20 Million	₩6.74 Billion ≈ $4.57 Million	0.134x	+31.71%
2020-12-31	₩44.38 Billion ≈ $30.08 Million	₩4.50 Billion ≈ $3.05 Million	0.101x	-26.55%
2019-12-31	₩40.16 Billion ≈ $27.22 Million	₩5.55 Billion ≈ $3.76 Million	0.138x	+1.17%
2018-12-31	₩35.72 Billion ≈ $24.20 Million	₩4.88 Billion ≈ $3.31 Million	0.137x	+127.43%
2017-12-31	₩35.22 Billion ≈ $23.87 Million	₩2.11 Billion ≈ $1.43 Million	0.060x	-34.18%
2016-12-31	₩32.98 Billion ≈ $22.35 Million	₩3.01 Billion ≈ $2.04 Million	0.091x	+719.39%
2015-12-31	₩24.27 Billion ≈ $16.45 Million	₩270.22 Million ≈ $183.12K	0.011x	-91.87%
2014-12-31	₩24.30 Billion ≈ $16.47 Million	₩3.33 Billion ≈ $2.25 Million	0.137x	--

About ilShinbiobase Co. Ltd

KQ:068330 Korea

Market Cap

$29.90 Million

₩44.12 Billion KRW

Market Cap Rank

#23896 Global

#1656 in Korea

Share Price

₩1058.00

Change (1 day)

+2.42%

52-Week Range

₩863.00 - ₩1058.00

All Time High

₩1058.00